Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05874479

Reducing AIR Pollution Exposure to Lower Blood PRESSURE Among New York City Public Housing Residents

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
440 (estimated)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

Fine particulate matter \<2.5 µm (PM2.5) air pollution is the fifth leading risk factor for global mortality, with the largest portion of deaths due to cardiovascular disease (CVD). While several mechanisms are responsible, PM2.5-induced elevations in blood pressure (BP) may be relevant. Indoor portable air cleaners (PACs) are a novel approach to reduce exposure to PM2.5 and potentially lower blood pressure. The current study is being conducted to provide evidence that PACs reduce PM2.5 exposure and lower systolic blood pressure (SBP) in key patient populations.

Conditions

Interventions

TypeNameDescription
DEVICEActive PACThe active PAC will contain HEPA filters inside the device.
DEVICESham PACThe sham PAC will contain no HEPA filters inside the device.

Timeline

Start date
2023-12-20
Primary completion
2027-09-01
Completion
2028-03-01
First posted
2023-05-25
Last updated
2025-10-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05874479. Inclusion in this directory is not an endorsement.